Amprenavir

Active ingredient description

Amprenavir is a competitive inhibitor of HIV-1 protease. Amprenavir binds to the active site of HIV-1 protease and thereby prevents the processing of viral gag and gag-pol polyprotein precursors, resulting in the formation of immature non-infectious viral particles.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
J05AE05
Amprenavir
J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AE Protease inhibitors
Discover more medicines within J05AE05

Structural formula

Graphic representation of the active ingredient's molecular structure

Unique ingredient identifier (UNII)

5S0W860XNR - AMPRENAVIR

CAS registry number

161814-49-9 - amprenavir

SNOMED-CT

387006009 - Amprenavir (substance)

 
Next: Usage >